Fast Like EpiPen: Mylan Reaches Quick Settlement Over Medicaid Rebates

$465m settlement with DOJ to resolve questions about EpiPen's classification is roughly the size of autoinjector's Medicaid and Medicare sales last year; Mylan expects to enter corporate integrity agreement.